JP2023505023A - 診断画像取得決定のための装置 - Google Patents

診断画像取得決定のための装置 Download PDF

Info

Publication number
JP2023505023A
JP2023505023A JP2022529069A JP2022529069A JP2023505023A JP 2023505023 A JP2023505023 A JP 2023505023A JP 2022529069 A JP2022529069 A JP 2022529069A JP 2022529069 A JP2022529069 A JP 2022529069A JP 2023505023 A JP2023505023 A JP 2023505023A
Authority
JP
Japan
Prior art keywords
data value
patient
threshold data
determining
image acquisition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022529069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505023A5 (https=
Inventor
デル ザーハ ピーテル ヤン ファン
ウィルヘルムス フランシスクス ヨハネス フェルハーフ
ヨヘン ケアップ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips NV filed Critical Koninklijke Philips NV
Publication of JP2023505023A publication Critical patent/JP2023505023A/ja
Publication of JP2023505023A5 publication Critical patent/JP2023505023A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30096—Tumor; Lesion
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30204—Marker

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Theoretical Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Quality & Reliability (AREA)
  • Urology & Nephrology (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2022529069A 2019-11-19 2020-11-17 診断画像取得決定のための装置 Pending JP2023505023A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19210005.5 2019-11-19
EP19210005.5A EP3826024A1 (en) 2019-11-19 2019-11-19 Apparatus for diagnostic image acquisition determination
PCT/EP2020/082312 WO2021099280A1 (en) 2019-11-19 2020-11-17 Apparatus for diagnostic image acquisition determination

Publications (2)

Publication Number Publication Date
JP2023505023A true JP2023505023A (ja) 2023-02-08
JP2023505023A5 JP2023505023A5 (https=) 2023-11-24

Family

ID=68771338

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022529069A Pending JP2023505023A (ja) 2019-11-19 2020-11-17 診断画像取得決定のための装置

Country Status (5)

Country Link
US (1) US12165319B2 (https=)
EP (2) EP3826024A1 (https=)
JP (1) JP2023505023A (https=)
CN (1) CN114730623A (https=)
WO (1) WO2021099280A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11838400B2 (en) * 2019-11-19 2023-12-05 International Business Machines Corporation Image encoding for blockchain
CN115294191B (zh) * 2022-10-08 2022-12-27 武汉楚精灵医疗科技有限公司 基于电子内镜的标志物尺寸测量方法、装置、设备及介质
CN121306515B (zh) * 2025-12-11 2026-03-24 陕西中医药大学附属医院 基于多模态影像的颅脑损伤区域精准识别方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017094805A1 (ja) * 2015-11-30 2017-06-08 株式会社Ｄｎａチップ研究所 ｃｔＤＮＡ量の測定による悪性新生物に対する治療の効果を評価する方法
EP3542859A1 (en) * 2018-03-20 2019-09-25 Koninklijke Philips N.V. Determining a medical imaging schedule

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7187790B2 (en) * 2002-12-18 2007-03-06 Ge Medical Systems Global Technology Company, Llc Data processing and feedback method and system
US7490085B2 (en) * 2002-12-18 2009-02-10 Ge Medical Systems Global Technology Company, Llc Computer-assisted data processing system and method incorporating automated learning
US20160032395A1 (en) * 2013-03-14 2016-02-04 Elai Davicioni Cancer biomarkers and classifiers and uses thereof
WO2014151117A1 (en) * 2013-03-15 2014-09-25 The Board Of Trustees Of The Leland Stanford Junior University Identification and use of circulating nucleic acid tumor markers
AU2016322966B2 (en) * 2015-09-17 2021-10-14 S.D. Sight Diagnostics Ltd Methods and apparatus for detecting an entity in a bodily sample
EP3241489A1 (en) * 2016-05-04 2017-11-08 Mensia Technologies Predictive neuromarkers of alzheimer's disease
GB201618485D0 (en) * 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
WO2018144044A1 (en) * 2017-02-03 2018-08-09 Q Bio, Inc. lTERATIVE MEDICAL TESTING OF BIOLOGICAL SAMPLES
US10646156B1 (en) * 2019-06-14 2020-05-12 Cycle Clarity, LLC Adaptive image processing in assisted reproductive imaging modalities
US11621077B2 (en) * 2019-09-30 2023-04-04 Kpn Innovations, Llc. Methods and systems for using artificial intelligence to select a compatible element

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017094805A1 (ja) * 2015-11-30 2017-06-08 株式会社Ｄｎａチップ研究所 ｃｔＤＮＡ量の測定による悪性新生物に対する治療の効果を評価する方法
EP3542859A1 (en) * 2018-03-20 2019-09-25 Koninklijke Philips N.V. Determining a medical imaging schedule

Also Published As

Publication number Publication date
US12165319B2 (en) 2024-12-10
WO2021099280A1 (en) 2021-05-27
US20230028306A1 (en) 2023-01-26
EP3826024A1 (en) 2021-05-26
CN114730623A (zh) 2022-07-08
EP4062414A1 (en) 2022-09-28

Similar Documents

Publication Publication Date Title
Zamagni et al. 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
Broocks et al. Computed tomography–based imaging of voxel-wise lesion water uptake in ischemic brain: relationship between density and direct volumetry
Leitner et al. High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases
Latifoltojar et al. Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response
Haznedar et al. Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma
Dercle et al. Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence
Gonzalez-Escamilla et al. PETPVE12: an SPM toolbox for partial volume effects correction in brain PET–application to amyloid imaging with AV45-PET
EP3048977B1 (en) Patient-specific analysis of positron emission tomography data
Perez-Lopez et al. Multiparametric magnetic resonance imaging of prostate cancer bone disease: correlation with bone biopsy histological and molecular features
Nishimatsu et al. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT
Wennmann et al. Deep learning for automatic bone marrow apparent diffusion coefficient measurements from whole-body magnetic resonance imaging in patients with multiple myeloma: a retrospective multicenter study
US20110077503A1 (en) Automatic MRI Quantification of Structural Body Abnormalities
Schaafsma et al. Optical mammography using diffuse optical spectroscopy for monitoring tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer
Buijsen et al. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer
JP2023505023A (ja) 診断画像取得決定のための装置
Brito et al. Evaluation of whole-body tumor burden with 68Ga-PSMA PET/CT in the biochemical recurrence of prostate cancer
Tutino et al. Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: interobserver agreement and reproducibility across software platforms
Wu et al. Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma
Peters et al. Assessment of cortical interruptions in the finger joints of patients with rheumatoid arthritis using HR‐pQCT, radiography, and MRI
JP7114323B2 (ja) 医用情報処理システム及び医用情報処理装置
Önner et al. Which of the fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography parameters are better associated with prognostic factors in breast cancer?
Ikeda et al. Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma
Verdier et al. Evaluation of a nnU-Net type automated clinical volumetric tumor segmentation tool for diffuse low-grade glioma follow-up
Santos et al. Whole-body tumor burden in PET/CT expert review
Vidiri et al. Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231115

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20241113

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250708